Navigation Links
PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA
Date:5/22/2009

ANNAPOLIS, Md., May 22 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, today announced that the Company has submitted its comprehensive regulatory strategy to the U.S. Food and Drug Administration (FDA) outlining the non-clinical and clinical development plans for licensure of SparVax(TM), a next generation recombinant protective antigen anthrax vaccine.

The FDA submission is in response to recent amendments issued by the Department of Health and Human Services (HHS) on April 15th and 22nd, 2009, to solicitation number RFP BARDA 08-15, outlining a requirement to develop and procure 25 million doses of a next generation rPA anthrax vaccine for the country's civilian biomedical stockpile.

In September 2008, PharmAthene received notification from HHS that its proposal for SparVax(TM) had been deemed technically acceptable and within the competitive range for procurement consideration. Since that time, PharmAthene has been engaged in negotiations with HHS under the proposals process.

David P. Wright, President and Chief Executive Officer of PharmAthene, noted, "We are pleased to have met our stated goal of submitting our regulatory plan to FDA by May 21st, well ahead of the June 15th submission deadline. We feel we have presented a comprehensive and credible path for the ultimate licensure of SparVax(TM). We continue to maintain an ongoing dialogue with FDA, and anticipate an expeditious review of our development plan. In the meantime, activities under the SparVax(TM) program continue to advance uninterrupted under a development contract for SparVax(TM) originally awarded by the National Institute of Allergy and Infectious Disease (NIAID) and transferred to the Biomedical Advanced Research and Deve
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. PharmAthene to Host a Conference Call and Webcast on Wednesday, April 29th at 4:30 PM to Provide an Update on the SparVax(TM) rPA Anthrax Vaccine Program
2. PharmAthene Initiates Phase I Clinical Trial of Nerve Agent Bioscavenger Protexia(R)
3. PharmAthene Presents Data for Protexia(R) and Valortim(R) at 2008 BARDA Industry Conference / PHEMCE Stakeholders Workshop
4. PharmAthenes Recombinant Butyrylcholinesterase (rBChE) May Play A Neuroprotective Role in Alzheimers Disease
5. PharmAthene to Webcast its Third Quarter Conference Call on November 13, 2007 at 4:30 P.M. Eastern Time
6. Human Genome Sciences Submits Biologics License Application to FDA for ABthrax(TM)
7. Cadence Pharmaceuticals Submits Acetavance New Drug Application for the Treatment of Acute Pain and Fever
8. D-Pharm Submits Investigational New Drug Application and Special Protocol Assessment to the FDA for Phase III Trial of DP-b99 in Acute Stroke Patients
9. AstraZeneca Submits NDA for Low Dose Aspirin/Esomeprazole Combination Product
10. U.S. Naval Medical Research Center Resubmits IND Application for Proposed RESUS Clinical Trial in Trauma Patients in the Out-of-Hospital Setting
11. ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... July 6, 2015 Cardinal Health today announced ... Group (THDG). A distributor of generic pharmaceuticals, over-the-counter medications and ... THDG was owned by Court Square Capital Partners. The ... cash and new debt.  Headquartered in ... Group had revenues of approximately $450 million in 2014. ...
(Date:7/6/2015)... Research and Markets( http://www.researchandmarkets.com/research/58tdl6/pharmaceutical ) has ... Chloride Market by Applications, by Region - Industry Trends ... The pharmaceutical grade sodium chloride market is ... and 2019 in terms of volume, and the consumption ... The report on Pharmaceutical grade sodium chloride market, ...
(Date:7/6/2015)... -- Celtaxsys, Inc., a clinical stage pharmaceutical development company ... orphan inflammatory disease indications, announced today that it has ... (FDA) to begin a Phase 2 clinical trial of ... patients in the US. The regulatory submissions to the ... be filed soon after. This groundbreaking clinical study, testing ...
Breaking Medicine Technology:Cardinal Health Completes Acquisition Of The Harvard Drug Group For $1.115 Billion 2Cardinal Health Completes Acquisition Of The Harvard Drug Group For $1.115 Billion 3Global Pharmaceutical Grade Sodium Chloride Market Report 2015 2Global Pharmaceutical Grade Sodium Chloride Market Report 2015 3Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 3
(Date:7/6/2015)... FL (PRWEB) , ... July 06, 2015 , ... ... key areas of orthopaedic sports medicine, the American Orthopaedic Society for Sports Medicine ... Annual Meeting, July 9-12 in Orlando, FL. As a leader in orthopaedic ...
(Date:7/6/2015)... , ... July 06, 2015 , ... Shortly after opening ... , the leading network of doctors working on a lien basis. Dr. Lim ... Liens. , The daughter of two Cambodian refugees, Dr. Lim suffered with back pain ...
(Date:7/6/2015)... ... July 06, 2015 , ... Invitation to ... yet there is a large gap between the unmet health priorities in the ... health outcomes and reduce unnecessary or ineffective treatments or procedures. , This milestone ...
(Date:7/6/2015)... ... July 06, 2015 , ... The Asian-Pacific market for rheumatoid arthritis therapeutics ... to grow at a CAGR of over 3.2 percent in the years to come ... to be mainly spurred by an anticipated launch of a number of promising pipeline ...
(Date:7/6/2015)... ... 06, 2015 , ... Understanding the new ICD-10 requirements is ... the transition. ADVOCATE, the only 100% radiology, revenue cycle management company in the ... The ten tips are timely and relevant guidelines to help radiology practices avoid ...
Breaking Medicine News(10 mins):Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 2Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 3Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 4Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 5Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 6Health News:Respected Chiropractor Opens Office in Signal Hill/Cambodia Town and Joins Doctors on Liens 2Health News:Columbia Nursing Nairobi Summit: Setting a Clinical Research Agenda for Africa 2Health News:APAC Rheumatoid Arthritis Therapeutics Market to Reach Value of USD 6.9 Billion by 2021, Says GBI Research in Its New Report Now Available at MarketPublishers.com 2Health News:ADVOCATE Takes the Lead to Ensure ICD-10 Success: “Top 10 Tips for ICD-10” 2
... to declare the production cost of new medicines, including ... Thai market, Siriwat Thiptaradol, secretary-general of Thailand's Food and ... ,According to Siriwat, the requirement to disclose ... bill being considered by the Office of the Council ...
... could survive. And they have, one in thirty. Such are ... // ,Most of these babies with disabilities ... all lived for no more than a few hours, according ... and Gynaecology study. ,About 190,000 abortions take place ...
... saga of the HPV vaccine seems to be following ... story of the Hepatitis B vaccine, //the subject of ... the merits of its inclusion in the mandatory immunization ... 250,000 Americans are down with Hepatitis B infection each ...
... seem to confirm that oatmeal is good for the heart. ... direct effect of eating oatmeal on reducing heart disease risk ... did produce an overall cholesterol-lowering effect. ,People ... products experienced a decrease in both total cholesterol and unhealthy ...
... percent surge in its profit at Rs.2 billion with a ... ,The firm's expenditure on research and development, during ... said in a statement. It also announced increase in dividend ... recommended by the court. ,"Our strategy of ...
... Health & Family Welfare, Smt. Panabaka Lakshmi Inaugurated the ... State Medicinal Plant// Boards on “Strategies for Conservation and ... ,The minister said that our strategies and action ... existing medicinal plants bio-diversity in the forest areas but ...
Cached Medicine News:Health News:Thailand Directs Pharma Companies to Declare Production Cost of Drugs 2Health News:Aborted Babies Survive, a British Study Says 2Health News:Wholegrain Oats may Help Lower Cholesterol 2Health News:Exports Of Herbal & Dietary Products Has Huge Potential 2
... ring electrodes feature a molded grip ... slider that moves smoothly and locks ... also feature ultraflexible, red-and-black, 61-cm (24-in) ... resistance of bend-relief protection at both ...
... bars made of silver/silver chloride have contacts ... easy separation into two individual tabs. For ... 17). Bar dimensions: 4 cm (1.6 in) ... 200-count package contains 50 individually sealed sets ...
... Video Camera System (NTSC)With Maxenon PowerPlus ... surgeon's eye view of any procedure. ... or digital files for later use. ... 8" to 36". Automatic Iris and ...
... and your patient warm, with the ... system.,Designed around the Coanda Effect, thousands ... air flow around your torso's blush ... the heat and stress induced environment ...
Medicine Products: